Sabinsa, the official curcumin sponsor of VitaFoods Europe, showcased its innovative products at the event in Geneva, Switzerland 10 – 12 May, 2022, in addition to presenting a scientific mini-seminar for their customers.
Some of Sabinsa’s IP protected, science-backed ingredients to be highlighted:
-
Curcumin C3 Reduct®, the first EFSA approved Curcuminoids metabolite
-
LivLonga®, for healthy liver support function, is an unique blend of three scientifically validated ingredients Curcumin C3 Complex®, Livinol™ and the bioavailability enhancer BioPerine®
-
Cirpusins® nutgrass root (Cyperus rotundus,) standardized to contain 5% stilbenes, supports a healthy body mass index
-
Shagandha® Ashwagandha Root Extract 2.5% USP from Withania somnifera, assured to comply with the U.S. Pharmacopoeia-National Formulary (USP-NF) monograph
LivLonga®, Sabinsa’s most recent clinically studied and IP protected product, was invited for display at the innovation zone during the event.
The Sabinsa team demonstrated product concepts including bars, jellies, gummies, and a Kombucha drink with the company’s extensively studied, shelf stable probiotic LactoSpore®, as well as a beauty-from-within drink formulated with C3 Reduct® and Saberry®.
On May 11, 19:00 hours Sabinsa conducted a scientific mini-seminar at the Hilton Conference Center, where R&D President, Dr. Kalyanam Nagabhushanam, gave presentation about Sabinsa’s latest innovations and Dr. Umar Jan, President European Operation gave presentation about latest market trends and innovations. Event was participated by more than 100 professionals from Nutraceutical industry.
